Stem cell research and regenerative medicine in 2014: First year of regenerative medicine in Japan

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

It is my great pleasure to announce that we were able to publish the Japan Issue in Stem Cells and Development, especially in this year 2014. This year, 2014, is said to be the First Year of Regenerative Medicine in Japan. This movement is likely to be based on the establishment of a new law system regarding regenerative medicine (an Act for Ensuring the Safety of Regenerative Medicine or the so-called Regenerative Medicine Law) and the partial revision of the Pharmaceutical Affairs Law (PAL). Both laws will come into effect in 2014 in this country. These new law systems are expected to have a great impact on the facilitation of R&D related to regenerative medicine and stem cell biology. In the present Japan Issue, some excellent stem cell research in this country will be introduced to celebrate the First Year of Regenerative Medicine in Japan.

Original languageEnglish
Pages (from-to)2127-2128
Number of pages2
JournalStem Cells and Development
Volume23
Issue number18
DOIs
Publication statusPublished - 2014 Sep 15

Fingerprint

Stem Cell Research
Regenerative Medicine
Japan
Stem Cells
Pleasure
Cell Biology
Safety
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology
  • Hematology
  • Medicine(all)

Cite this

Stem cell research and regenerative medicine in 2014 : First year of regenerative medicine in Japan. / Okano, Hideyuki.

In: Stem Cells and Development, Vol. 23, No. 18, 15.09.2014, p. 2127-2128.

Research output: Contribution to journalArticle

@article{1272783f27e24885ab55fddd2f03769c,
title = "Stem cell research and regenerative medicine in 2014: First year of regenerative medicine in Japan",
abstract = "It is my great pleasure to announce that we were able to publish the Japan Issue in Stem Cells and Development, especially in this year 2014. This year, 2014, is said to be the First Year of Regenerative Medicine in Japan. This movement is likely to be based on the establishment of a new law system regarding regenerative medicine (an Act for Ensuring the Safety of Regenerative Medicine or the so-called Regenerative Medicine Law) and the partial revision of the Pharmaceutical Affairs Law (PAL). Both laws will come into effect in 2014 in this country. These new law systems are expected to have a great impact on the facilitation of R&D related to regenerative medicine and stem cell biology. In the present Japan Issue, some excellent stem cell research in this country will be introduced to celebrate the First Year of Regenerative Medicine in Japan.",
author = "Hideyuki Okano",
year = "2014",
month = "9",
day = "15",
doi = "10.1089/scd.2014.0200",
language = "English",
volume = "23",
pages = "2127--2128",
journal = "Stem Cells and Development",
issn = "1547-3287",
publisher = "Mary Ann Liebert Inc.",
number = "18",

}

TY - JOUR

T1 - Stem cell research and regenerative medicine in 2014

T2 - First year of regenerative medicine in Japan

AU - Okano, Hideyuki

PY - 2014/9/15

Y1 - 2014/9/15

N2 - It is my great pleasure to announce that we were able to publish the Japan Issue in Stem Cells and Development, especially in this year 2014. This year, 2014, is said to be the First Year of Regenerative Medicine in Japan. This movement is likely to be based on the establishment of a new law system regarding regenerative medicine (an Act for Ensuring the Safety of Regenerative Medicine or the so-called Regenerative Medicine Law) and the partial revision of the Pharmaceutical Affairs Law (PAL). Both laws will come into effect in 2014 in this country. These new law systems are expected to have a great impact on the facilitation of R&D related to regenerative medicine and stem cell biology. In the present Japan Issue, some excellent stem cell research in this country will be introduced to celebrate the First Year of Regenerative Medicine in Japan.

AB - It is my great pleasure to announce that we were able to publish the Japan Issue in Stem Cells and Development, especially in this year 2014. This year, 2014, is said to be the First Year of Regenerative Medicine in Japan. This movement is likely to be based on the establishment of a new law system regarding regenerative medicine (an Act for Ensuring the Safety of Regenerative Medicine or the so-called Regenerative Medicine Law) and the partial revision of the Pharmaceutical Affairs Law (PAL). Both laws will come into effect in 2014 in this country. These new law systems are expected to have a great impact on the facilitation of R&D related to regenerative medicine and stem cell biology. In the present Japan Issue, some excellent stem cell research in this country will be introduced to celebrate the First Year of Regenerative Medicine in Japan.

UR - http://www.scopus.com/inward/record.url?scp=84906993512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906993512&partnerID=8YFLogxK

U2 - 10.1089/scd.2014.0200

DO - 10.1089/scd.2014.0200

M3 - Article

C2 - 25192239

AN - SCOPUS:84906993512

VL - 23

SP - 2127

EP - 2128

JO - Stem Cells and Development

JF - Stem Cells and Development

SN - 1547-3287

IS - 18

ER -